Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 4, 2005 - Issue 5
Submit an article Journal homepage
72
Views
10
CrossRef citations to date
0
Altmetric
Review

Safety of antiepileptic drugs during pregnancy

Stephen J Hunt Royal Victoria Hospital, Grosvenor Road, Belfast, BT12 6BA, UK. [email protected]
&
Jim I Morrow Royal Victoria Hospital, Grosvenor Road, Belfast, BT12 6BA, UK. [email protected]
Pages 869-877 | Published online: 07 Sep 2005

Bibliography

  • HAUSER WA, ANNEGERS JF, ROCCA WA: Descriptive epidemiology of epilepsy: contributions of population-based studies from Rochester, Minnesota. Mayo Chi]. Proc. (1996) 71:576–586.
  • DANSKY LV, FINNELL LV: Parental epilepsy, anticonvulsant drugs, and reproductive outcome: epidemiological and experimental findings spanning three decades; 2: human studies. Reprod. Toxicol (1991) 5:301–335.
  • OLAFSSON E, HALLGRIMSSON JT, HAUSER WA, LUDVIGSSON P, GUDMUNDSSON G: Pregnancies of women with epilepsy: a population-based study in Iceland. Epllepsia (1998) 39:887–892.
  • FAIRGRIEVE SD, JACKSON M, JONAS P et al.: Population-based, prospective study of the care of women with epilepsy in pregnancy. BE Med. J. (2000) 321:674–675.
  • RUSSELL AJ, MACPHERSON H, CAIRNIE V, BRODIE MJ: The care of pregnant women with epilepsy - a survey of obstetricians in Scotland. Seizure (1996) 5:271–277.
  • VINTEN J, ADAB N, KINI U, GORRY J, GREGG J, BAKER GA: Neuropsychological effects of exposure to anticonvulsant medication in utero. Neurology (2005) 64:949–953.
  • FINNELL RH, SHIELDS HE, TAYLOR SM et al: Strain differences in phenobarbital-induced teratogenesis in mice. Teratology (1987) 35:177–185
  • MCELHATTON PR, SULLIVAN FM, TOSELAND PA: Teratogenic activity and metabolism of primidone in the mouse. Epilepsia (1977) 18:1–11.
  • HOLMES LB, WYSZYNSKI DF, LIEBERMAN E: The AED (antiepileptic drug) pregnancy registry: a 6-year experience. Arch. Neurol (2004) 61:673–678.
  • SAMREN EB, VAN DUIJN CM, CHRISTIAENS GC, HOFMAN A, LINDHOUT D: Antiepileptic drug regimens and major congenital abnormalities in the offspring. Ann. Neurol (1999) 46:739–746.
  • •Broad ranging retrospective cohort study.
  • HARTSFIELD JK Jr, HOLMES LB, MOREL JG: Phenytoin embryopathy: effect of epoxide hydrolase inhibitor on phenytoin exposure in utero in C57BL/6J mice. Teratology (1983) 28:1–8.
  • FINNELL RH, DANSKY LV: Parental epilepsy, anticonvulsant drugs, and reproductive outcome: epidemiologic and experimental findings spanning three decades; 1: Animal studies. Reprod. Toxicol (1991) 5:281–299
  • HIRSCHBERGER M, KLEINBERG F. Maternal phenytoin ingestion and congenital abnormalities: report of a case. Am. J. Dis. Child. (1975) 129:984.
  • ARPINO C, BRESCIANINI S, ROBERT E et al.: Teratogenic effects of antiepileptic drugs: use of an International Database on Malformations and Drug Exposure (MADRE). Epilepsia (2000) 41:1436–1443.
  • HANSON JW, SMITH DW: The fetal hydantoin syndrome. Pediatr. (1975) 87:285–290.
  • ROSA FW: Spina bifida in infants of women treated with carbamazepine during pregnancy. N Engl. I Med. (1991) 324:674–677.
  • GRANSTROM ML, HIILESMANN VK: Malformations and minor anomalies in children of epileptic mothers: preliminary results of the prospective Helsinki study. In: Epilepsy Pregnancy, and the Child Janz D, Dam M, Richens A, Bossi L Helge H and Schmidt D (Eds), Raven Press, NY, USA (1992):251–258.
  • DIAV-CITRIN 0, SHECHTMAN S, ARNON J, ORNOY A: Is carbamazepine teratogenic? A prospective controlled study of 210 pregnancies. Neurology (2001) 57:321–324.
  • SAMREN EB, VAN DUIJN CM, KOCH S et al: Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy. Epilepsia (1997) 38:981–990.
  • KAAJA E, KAAJA R, HIILESMAA V: Major malformations in offspring of women with epilepsy. Neurology. (2003) 60:575–579.
  • FAIELLA A, WERNIG M, CONSALEZ GG et al.: A mouse model for valproate teratogenicity: parental effects, homeotic transformations, and altered HOX expression. Hum. Ma. Genet. (2000) 22:227–236.
  • DUNCAN S, MERCHO S, LOPES-CENDES I et al: Repeated neural tube defects and valproate monotherapy suggest a pharmacogenetic abnormality. Epilepsia (2001) 42:750–753.
  • MALM H, KAJANTIE E, KIVIRIKKO S, KAARIAINEN H, PEIPPO M, SOMER M: Valproate embryopathy in three sets of siblings: further proof of hereditary susceptibility. Neurology. (2002) 59:630–633.
  • OMTZIGT JG, LOS FJ, GROBBEE DE et al: The risk of spina bifida aperta after first-trimester exposure to valproate in a prenatal cohort. Neurology (1992) 42(4 Suppl. 5):119–125.
  • LINDHOUT D, OMTZIGT JG, CORNEL MC: Spectrum of neural-tube defects in 34 infants prenatally exposed to antiepileptic drugs. Neurology (1992) 42(4 Suppl. 5):111–118.
  • KOCH S, LOSCHE G, JAGER-ROMAN E et al: Major and minor birth malformations and antiepileptic drugs. Neurology (1992) 42(4 Suppl. 5):83–88.
  • VAJDA FJ, O'BRIEN TJ, HITCHCOCK A et al: Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian register of anti-epileptic drugs in pregnancy. I Clin. NeuroscL (2004) 11:854–8.
  • Committee on Safety of Medicines. Sodium valproate and prescribing in pregnancy. Current Problems in Pharmacovigilance (2003) 29:6.
  • •Impact of emerging data on health policy.
  • WYSZYNSKI DF, NAMBISAN M, SURVE T, ALSDORF RIVI, SMITH CR, HOLMES LB: Increased rate of major malformations in offspring exposed to valproate during pregnancy. Neurology (2005) 64:961–965.
  • ADAB N, JACOBY A, SMITH D, CHADWICK D: Additional educational needs in children born to mothers with epilepsy. I Neurol Neurosurg. Psychiatry (2001) 70:15–21.
  • •Highlighting developmental concerns.
  • ADAB N, KINI U, VINTEN J et al: The longer term outcome of children born to mothers with epilepsy. J. Neurol Neurosurg. Psychiatry (2004) 75:1575–1583.
  • GAILY E, KANTOLA-SORSA E, HIILESMAA V et al.: Normal intelligence in children with prenatal exposure to carbamazepine. Neurology (2004) 13:28–32.
  • ABDULRAZZAQ YM, BASTAKI SM, PADMANABHAN R: Teratogenic effects of vigabatrin in TO mouse fetuses. 7eratology (1997) 55:165–176.
  • CUNNINGTON M, TENNIS P: Lamotrigine and the risk of malformations in pregnancy. Neurology (2005) 64:955–960.
  • PETRERE JA, ANDERSON JA: Developmental toxicity studies in mice, rats, and rabbits with the anticonvulsant gabapentin. Fundam. AppL Toxicol (1994) 23:585–589.
  • MONTOURIS G: Gabapentin exposure in human pregnancy: results from the Gabapentin Pregnancy Registry. Epilepsy Behav. (2003) 4:310–317.
  • WILTON LV, SHAKIR S: A postmarketing surveillance study of gabapentin as add-on therapy for 3,100 patients in England. Epilepsia (2002) 43:983–992.
  • LEPPIK IE, GRAM L, DEATON R et al: Safety of tiagabine: summary of 53 trials. Epilepsy Res. (1999) 33:235–246.
  • OHMAN I, VITOLS S, LUEF G et al.: Topiramate kinetics during delivery, lactation, and in the neonate: preliminary observations. Epilepsia (2002) 43:1157–1160.
  • BENNETT GD, AMORE BM, FINNELL RH et al.: Teratogenicity of carbamazepine-10, 11-epoxide and oxcarbazepine in the SWV mouse. Pharmacol Exp. Ther. (1996) 279:1237–1242.
  • MEISCHENGUISER R, D'GIONO CH, FERRARO SM: Oxcarbazepine in pregnancy: clinical experience in Argentina. Epilepsy Behav. (2004) 5:163–167.
  • ISOHERRANEN N, SPIEGELSTEIN 0, BIALER M et al.: Developmental outcome of levetiracetam, its major metabolite in humans, 2-pyrrolidinone N-butyric acid, and its enantiomer (R)-alpha-ethyl-oxo-pyrrolidine acetamide in a mouse model of teratogenicity. Epilepsia (2003) 44:1280–1288
  • LONG L: Levetiracetam monotherapy during pregnancy: a case series. Epilepsy Behav. (2003) 4:447–448.
  • HUNT SJ, CRAIG JJ, IRWIN B et al: Levetiracetam therapy in human pregnancy: preliminary experience from The UK Epilepsy and Pregnancy Register.
  • th IBE/ILAE International Epilepsy Congress. Paris, France (2005).
  • •Largest series of pregnancies exposed to levetiracetam.
  • KONDO T, KANEKO S, AMANO Y et al.: Preliminary report on teratogenic effects of zonisamide in the offspring of treated women with epilepsy. Epllepsia (1996) 37:1242–1244.
  • OHTAHARA S, YAMATOGI Y: Safety of zonisamide therapy: prospective follow-up survey. Seizure (2004) 13 (Supp1.1):S50–S55
  • TOMSON T, LINDBOM U, EKQVIST B et al.: Epilepsy and pregnancy: a prospective study of seizure control in relation to free and total plasma concentrations of carbamazepine and phenytoin.Epilepsia (1994) 35:122–130.
  • SCHMIDT D, CANGER R, AVANZINI G et al.: Change of seizure frequency in pregnant epileptic women. Neurol Neurosurg. Psychiatry (1983) 46:751–755.
  • CHOULIKA S, GRABOWSKI E, HOLMES LB: Is antenatal vitamin K prophylaxis needed for pregnant women taking anticonvulsants? Am. Obstet. Cynecol (2004) 190:882–883.

Websites

  • http://emc.medicines.org.uldemc/assets/c/ html/displaydoc.asp?documentid=4992 SPC from EMC (2004).
  • http://www.fda.gov/medwatch/SAFETY/ 192004/jan_PI/Lamictal_PI.pdf FDA product characteristics (2004).
  • http://www.fda.gov/medwatch/SAFETY/ 192005/Gabitril_PUeb2005.pdf FDA product characteristics (2005).
  • http://www.fda.gov/medwatch/SAFETY/ 192004/aug_PI/Topamax_PI.pdf FDA product characteristics (2004).
  • http://www.fda.gov/cder/foillabe1/2003/ 21014se5-003_trileptal_lbl.pdf FDA product characteristics (2003).
  • http://www.emea.eu.int/humandocs/PDFs/ EPAR/lyrica/084504en6.pdf. EMEA press release (2004).
  • http://www.fda.gov/medwatch/SAFETY/ 192002/Zonegran_PI.pdf FDA product characteristics (2002).
  • http://www.emea.eu.int/pdfs/human/ opinion/ 1919065704en.pdf EMEA press release (2004).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.